AO-3RT/Cag is a research compound that scientists use in studies on weight control and energy balance. AO-3RT/Cag combines a triple-receptor activator with an amylin analog. Together, they form a dual-pathway model for studying appetite, fullness, and energy use in lab settings. As a result, researchers value this compound for showing how hormone signals affect body weight and energy control.
In lab tests, AO-3RT acts on GLP-1, GIP, and GCG (glucagon) receptors. This wide activity supports work on glucose control, appetite, and fat use. It also helps scientists understand how the body manages and uses energy.
The Amylin analog works on the amylin receptor pathway, which links to feelings of fullness and reduced food intake. By combining these two parts, AO-3RT/Cag helps researchers study how both systems work together to affect appetite and energy use. Therefore, the compound offers a simple and modern way to explore long-term weight studies.
Researchers also study AO-3RT/Cag for its effects on heart health, insulin response, and energy use. In addition, its broad role makes it a reliable tool for research on weight, diet, and metabolism.
